CystsDETECTIONNCT05839678
How to Differentiate and Treat Cystic Laesions in the Anterior Mediastinum (DETECTION)
An observational study of Cysts, run by Maastricht University Medical Center at 1 site in Netherlands.
Trial summary
Multicenter trial about anterior mediastinal cysts Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Cysts
- How many people
- 200 participants
- Where
- 1 siteNetherlands
- Study dates
- 1 Dec 2022to 1 Dec 2027
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: Patients with cysts in the anterior mediastinum
Who may be able to join
- Thymic cysts
- Bronchogenic cysts
- Pericardial cysts
- Cystic thymoma
- Cystic teratoma
Who cannot join
- Patients <18 years old
- Patients without radiological imaging
- Patients without approval for follow-up
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Netherlands1 site, 1 recruiting
- Recruiting
Maastricht UMC
Maastricht, Limburg
Florit Marcuse, +31433876009, secretariaat.metc@mumc.nl
About this study
Multicenter trial about anterior mediastinal cysts
- Conditions
- Cysts
- Medical subject headings
- Cysts
What is being measured
The primary outcome is the main question the study is designed to answer.
Percentage correctly diagnosed cystic laesions
Measured: 2000-2022
Secondary outcomes (1)
Patient characteristics, complications, comborbidities
Measured: 2000-2022
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 May 2023
- Study start1 Dec 2022
- Primary completion1 Dec 2027 (estimated)
- Study completion1 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CystsStudies of the same condition, open and under way.
- More trials run by Maastricht University Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Other
- Enrolment
- 200 participants (estimated)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- Maastricht University Medical Center
- Sponsor type
- University, hospital or other
- Collaborators
- Erasmus Medical Center, The Netherlands Cancer Institute
- Responsible party
- Principal investigator, Florit Marcuse, Maastricht University Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05839678
- Sponsor's protocol ID
- 2022-3413
- Acronym
- DETECTION
- Status last verified
- Nov 2024
- First submitted
- 20 Apr 2023
- Last updated
- 20 Nov 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Nov 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- How to Differentiate and Treat Cystic Laesions in the Anterior Mediastinum (DETECTION)
- ClinicalTrials.gov ID
- NCT05839678
- Acronym / sponsor ID
- DETECTION / 2022-3413
- Conditions
- Cysts
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Maastricht University Medical CenterUniversity, hospital or other
- Collaborators
- Erasmus Medical Center, The Netherlands Cancer Institute
- Study start
- 1 Dec 2022 (actual)
- Primary completion
- 1 Dec 2027 (estimated)
- Study completion
- 1 Dec 2027 (estimated)
- First posted
- 3 May 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Multicenter trial about anterior mediastinal cysts
Study design
- Observational model
- Other
- Time perspective
- Other
- Target follow-up
- 1 Day
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Patients with cysts in the anterior mediastinum
Key inclusion criteria (5 listed)
- Thymic cysts
- Bronchogenic cysts
- Pericardial cysts
- Cystic thymoma
- Cystic teratoma
Key exclusion criteria (3 listed)
- Patients <18 years old
- Patients without radiological imaging
- Patients without approval for follow-up
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Percentage correctly diagnosed cystic laesions
Time frame: 2000-2022
1 secondary outcome
Patient characteristics, complications, comborbidities
Time frame: 2000-2022
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Nov 2024.
Related trials for Cysts
Recruiting
Efficacy of Ovarian Drilling Via vNOTES Laparoscopy in Patients With PCOS
PCOS (Polycystic Ovary Syndrome)
RecruitingObservational study
Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.
Inherited Disease, Rare Diseases
Not yet recruitingObservational study
AI-Assisted Differentiation of Pancreatic Cystic Lesions Using EUS Images and Clinical Features
Pancreatic Mucinous Cystic Neoplasm, Pancreatic Serous Cystic Neoplasm
RecruitingObservational study
Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
Kidney Neoplasms, Kidney Cancer
RecruitingObservational study
The Value of LC-MS/MS Detection of Androgen Profiles in the Diagnosis of PCOS: A Prospective, Multicenter Real-world Study
Polycystic Ovary Syndrome (PCOS)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cysts, run by Maastricht University Medical Center at 1 site in Netherlands.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 20 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percentage correctly diagnosed cystic laesions (time frame: 2000-2022). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Nov 2024.